Paul Govern

Study explores possible drug target for neurological problems

A team at Case Western Reserve University and Vanderbilt University Medical Center has determined with atomic-level precision how two established drugs bind to and alter the conformation of a cell membrane transporter protein called NKCC1, shutting down its activity.

Jenny Slayton, DNP, RN, Senior Vice President for (QSRP) spoke to VUMC leaders about a new awards program — the QSRP Pursuit of Excellence Award.

New QSRP awards program

A new awards program will recognize quality and safety improvement excellence across Vanderbilt Health.

Study to search EHR for undiagnosed genetic diseases

A team at Vanderbilt University Medical Center will explore computational solutions to help address the problem of missed or delayed diagnosis for patients with rare genetic diseases.

VUH adopts enhanced recovery for sarcoma surgery

Vanderbilt’s latest enhanced recovery after surgery clinical pathway was launched last month for adult patients receiving surgery to remove extremity soft tissue sarcomas, which are cancerous tumors that can arise in muscles, tendons, fat, blood vessels and other connective tissue.

Gene tied to childhood epilepsy

Data drawn from four unrelated patients with a childhood epilepsy syndrome — and from in vitro and in vivo studies — link novel variants in a GABA transporter gene to seizure activity, Vanderbilt researchers reported.

Gregory inducted into Tennessee Health Care Hall of Fame

Vanderbilt’s David Gregory, MD, associate professor of Medicine, emeritus, is among five honorees who will be inducted Oct. 18 to the Tennessee Health Care Hall of Fame.

1 6 7 8 9 10 48